Topic

Florida

A collection of 504 issues

How to Get Photrexa (Riboflavin) Covered by Aetna CVS Health in Florida: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Photrexa Covered by Aetna CVS Health in Florida Photrexa (riboflavin ophthalmic solution) requires prior authorization from Aetna CVS Health in Florida. Submit PA request through Availity provider portal with: keratoconus progression documentation (Kmax values), failed conservative treatments, FDA-approved iLink system confirmation. Standard decision: 30-45 days. If denied,
6 min read

How to Get Signifor / Signifor LAR (pasireotide) Covered by Aetna (CVS Health) in Florida: Complete PA Forms and Appeals Guide

Quick Answer: Getting Signifor / Signifor LAR (pasireotide) Covered by Aetna (CVS Health) in Florida Signifor / Signifor LAR (pasireotide) requires prior authorization from Aetna (CVS Health) in Florida. For acromegaly, you'll need documented failure of first-generation somatostatin analogs (octreotide, lanreotide) plus elevated IGF-1 levels. For Cushing's disease,
6 min read

Getting Imbruvica (Ibrutinib) Covered by Humana in Florida: Complete 2025 Guide to Prior Authorization, Appeals, and Cost Savings

Answer Box: Fastest Path to Imbruvica Coverage with Humana in Florida Imbruvica (ibrutinib) requires prior authorization from Humana Medicare plans but is covered for FDA-approved indications like CLL and Waldenström macroglobulinemia. Submit your PA request through an authorized specialty pharmacy (Biologics, Onco360, or Optum Specialty) with complete diagnostic records, pathology
7 min read

How to Get Gilenya (fingolimod) Covered by Cigna in Florida: Prior Authorization, Appeals, and Success Strategies

Answer Box: Getting Gilenya (fingolimod) Covered by Cigna in Florida Cigna requires prior authorization for Gilenya (fingolimod) with step therapy, baseline testing (EKG, eye exam, labs), and specialist prescription. Submit via CoverMyMeds or fax to 1-866-873-8279 with medical necessity documentation. If denied, request peer-to-peer review (1-800-882-4462) within 24-48 hours, then
7 min read

How to Get Jakafi (Ruxolitinib) Covered by Humana in Florida: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Jakafi (Ruxolitinib) Covered by Humana in Florida Humana Medicare Advantage plans in Florida cover Jakafi (ruxolitinib) on Tier 5 (specialty tier) with prior authorization required for myelofibrosis, polycythemia vera, and GVHD indications. Your prescriber must submit documentation proving hydroxyurea failure (for PV) or intermediate/high-risk disease status
5 min read

Work With Your Doctor to Get Breyanzi (Lisocabtagene Maraleucel) Approved by UnitedHealthcare in Florida: Complete Provider Collaboration Guide

Quick Answer: Getting Breyanzi Approved in Florida Breyanzi (lisocabtagene maraleucel) requires UnitedHealthcare prior authorization for relapsed/refractory large B-cell lymphoma or CLL/SLL after ≥2 prior therapies. Your oncologist must submit documentation showing progression after standard treatments, confirm CD19 positivity, and demonstrate you meet FDA labeling criteria. Treatment must occur
6 min read

How to Get Garadacimab (Andembry) Covered by Humana in Florida: Formulary Alternatives, Appeals, and Prior Authorization Guide

Answer Box: Getting Garadacimab Covered by Humana in Florida Garadacimab (Andembry) is not on Humana's 2025 formulary, requiring a formulary exception with medical necessity documentation. Your fastest path: (1) Try preferred alternatives like Haegarda or Cinryze first if medically appropriate, (2) Document failure/intolerance to alternatives, then (3)
6 min read

How to Get Enhertu (fam-trastuzumab deruxtecan-nxki) Covered by Aetna CVS Health in Florida: Complete Prior Authorization Guide and Appeals Process

Answer Box: Getting Enhertu Covered by Aetna CVS Health in Florida Enhertu (fam-trastuzumab deruxtecan-nxki) requires prior authorization from Aetna CVS Health for all FDA-approved indications. The fastest path to approval: (1) Submit Aetna's Enhertu precertification form (GR-69531 5-24) with HER2 testing results and prior therapy documentation, (2) Include
6 min read